Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
Pumpkin patches, fall and Halloween events in NC
Recommended
Climate change is reshaping North Carolina's fall colors
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about OncoBeta GmbH
Recent news which mentions OncoBeta GmbH
Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
July 11, 2023
Tickers
EPIC
Tags
Munich
Research
Epic
From
PRLog
GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
May 17, 2023
Tags
Germany
Australia
Basal Cell Carcinoma
From
PRLog
Latest research shows Australians still not getting annual skin checks with a Health Professional
March 01, 2023
Tags
Single/session
Munich
Research
From
PRLog
South African skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
December 22, 2022
Tags
Squamous Cell Carcinoma
Germany
Clinical Study
From
PRLog
'Spot Detective' – Check your spots this summer
November 22, 2022
Tags
Skin Check
Melanoma
Research
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
Research
England
Munich
From
PRLog
German skin cancer patients join the EPIC-Skin study
July 28, 2022
Tags
Painless
Germany
Rostock
From
PRLog
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
June 15, 2022
Tags
EPIC/Skin
Western Australia
Beauty
From
PRLog
OncoBeta launches International Registry for Non-Melanoma Skin Cancer
November 24, 2021
Tags
Bavaria
International Registry
Health
From
PRLog
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.